Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > agents & regimens > telcyta

Telcyta (TLK286) : Telik : small molecule compound

Telcyta (Telik)
Manufacturer's information on Telcyta, a targeted cancer therapy. Describes how Telcyta works against cancer and reviews clinical trials status.

TELCYTA (TLK286) - Recent MEDLINE Abstracts (PubMed)

TELCYTA (TLK286) - Clinical Trials (ClinicalTrials.gov)


 

Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2006, Lung Cancer Online Foundation
Last modified: 26-Apr-2011
Karen Parles, MLS Editor